根治性前列腺切除术后切缘阳性处Gleason分级与生化复发风险的系统评价与荟萃分析
结果显示切缘阳性处PGG 4或5及GGG>1均与生化复发风险显著升高相关。
要点
- 切缘阳性处PGG 4或5预测生化复发HR 1.66(95%CI 1.37-2.02,P<0.01)。
- 切缘阳性处GGG>1较GGG 1生化复发风险显著升高,且随GGG级别增加而递增。
- 多数研究以生化复发为替代终点,其他肿瘤学结局证据有限。
核心结论
- 根治性前列腺切除术后阳性手术切缘处的Gleason评分、原发Gleason分级和Gleason分级分组与生化复发风险显著增加相关。
研究设计与样本
- 阳性手术切缘队列样本量200至956例,中位随访1.5至13年。
- 主要结局为生化复发,次要结局包括癌症特异性生存、无转移生存和总死亡率。
主要发现
- 切缘阳性处PGG 4或5预测生化复发(HR 1.66,95%CI 1.37-2.02;P<0.01)。
- 切缘阳性处GGG 1 vs 2预测生化复发(HR 2.35,95%CI 1.6-3.46;P<0.001)。
- 切缘阳性处GGG 1 vs 3预测生化复发(HR 3.95,95%CI 1.82-8.57;P=0.005)。
- 切缘阳性处GGG 1 vs 4预测生化复发(HR 7.17,95%CI 1.76-29.17;P=0.006)。
- 切缘阳性处GGG 1 vs 5预测生化复发(HR 12.37,95%CI 1.80-84.82;P=0.01)。
关键数值与推荐
- 仅两项研究报告了生化复发以外的其他肿瘤学结局。
临床怎么用
- 对于根治性前列腺切除术后切缘阳性的患者,应关注切缘处的Gleason评分、原发Gleason分级和Gleason分级分组,以辅助评估生化复发风险。
局限性
- 多数研究以生化复发作为疾病进展的替代标志物,仅两项研究报告了其他肿瘤学结局。
- 需要更长期的研究来探讨切缘阳性处PGG、GS或GGG预测癌症特异性生存、无转移生存和总生存的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systematically review and perform a meta-analysis of studies investigating the role of primary Gleason grade (PGG), Gleason score (GS) or Gleason grade group (GGG) at positive surgical margins (PSMs) after radical prostatectomy (RP) in predicting biochemical recurrence (BCR) and oncological outcomes. METHODS: A systematic search was conducted using the MEDLINE, Scopus, Embase and Cochrane databases according to Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. Studies published between 2005 and 2019 were included. The quality of the studies selected was assessed, and a protocol was registered and published in advance (PROSPERO: CRD42019131800). The primary outcome measure was BCR. Secondary outcome measures included cancer-specific survival, metastasis-free survival and overall mortality during the follow-up period. RESULTS: Our systematic search yielded 3116 unique results. Ten studies were selected for meta-analysis. The sample sizes of PSM cohorts varied from 200 to 956, while the median follow-up ranged from 1.5 to 13 years. Most studies used BCR as a surrogate marker for disease progression; only two studies reported other oncological outcomes. Meta-analysis was performed in selected groups (PGG, GS and GGG). PGG 4 or 5 at the PSM was found to be predictive of BCR (hazard ratio [HR] 1.66, 95% confidence interval [CI] 1.37-2.02; P < 0.01). GGG > 1 at margin was also predictive of BCR compared to GGG 1 (GGG 1 vs 2: HR 2.35, 95% CI 1.6 -3.46; P < 0.001; GGG 1 vs 3: HR 3.95, 95% CI 1.82-8.57; P = 0.005; GGG 1 vs 4: HR 7.17, 95% CI 1.76-29.17; P = 0.006; and GGG 1 vs 5: HR 12.37, 95% CI 1.80-84.82; P = 0.01). CONCLUSION: Gleason score, PGG and GGG at the PSM are associated with a significantly increased risk of BCR. Longer-term studies are needed to investigate the utility of PGG, GS or GGG at the PSM in their ability to predict not only BCR but other outcomes such as cancer-specific survival, metastasis-free survival and overall survival.
引用
- John A, John H, Catterwell R, et al. Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta-analysis. BJU Int. 2021. PMID: 33973331. doi:10.1111/bju.15316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。